2024 Q2 Form 10-Q Financial Statement

#000173112224000812 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $4.327M $5.276M $8.877M
YoY Change -46.74% -40.56% 50.82%
Cost Of Revenue $4.124M $4.999M $5.655M
YoY Change -29.67% -11.61% 63.85%
Gross Profit $202.3K $277.3K $3.222M
YoY Change -91.05% -91.39% 32.35%
Gross Profit Margin 4.68% 5.26% 36.29%
Selling, General & Admin $756.0K $694.0K $1.023M
YoY Change -17.33% -32.14% 49.88%
% of Gross Profit 373.61% 250.24% 31.74%
Research & Development $344.8K $149.7K $702.6K
YoY Change 31.86% -78.7% 217.16%
% of Gross Profit 170.4% 53.98% 21.81%
Depreciation & Amortization $435.0K $425.3K $218.3K
YoY Change 52.85% 94.83% 172.54%
% of Gross Profit 214.96% 153.36% 6.78%
Operating Expenses $4.861M $2.821M $5.591M
YoY Change -8.36% -49.56% 60.56%
Operating Profit -$4.659M -$2.543M -$2.370M
YoY Change 53.05% 7.33% 126.07%
Interest Expense $145.9K $169.0K $213.0K
YoY Change -24.92% -20.66% -269.95%
% of Operating Profit
Other Income/Expense, Net $139.9K $208.0K $541.1K
YoY Change -87.74% -61.55% -477.93%
Pretax Income -$4.519M -$2.335M -$1.828M
YoY Change 137.39% 27.71% 53.48%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.946M -$1.686M -$1.828M
YoY Change 54.73% -7.78% 53.48%
Net Earnings / Revenue -68.08% -31.96% -20.6%
Basic Earnings Per Share -$0.31 -$0.18 -$0.12
Diluted Earnings Per Share -$0.31 -$0.18 -$0.12
COMMON SHARES
Basic Shares Outstanding 9.520M shares 9.520M shares 9.520M shares
Diluted Shares Outstanding 9.520M shares 9.520M shares 9.520M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.92M $17.12M $23.46M
YoY Change -47.24% -27.01% 57.54%
Cash & Equivalents $13.93M $16.14M $21.02M
Short-Term Investments $995.2K $982.6K $2.435M
Other Short-Term Assets $396.1K $677.4K $618.6K
YoY Change -12.89% 9.51% -40.62%
Inventory $4.148M $3.890M $4.797M
Prepaid Expenses
Receivables $115.8K $90.87K $625.3K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $19.58M $21.78M $28.56M
YoY Change -42.3% -23.73% 126.51%
LONG-TERM ASSETS
Property, Plant & Equipment $13.51M $13.89M $6.154M
YoY Change 41.34% 125.73% 79.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $942.7K
YoY Change -68.36%
Other Assets $48.71K $48.71K $32.52K
YoY Change 2.5% 49.78% 30.08%
Total Long-Term Assets $14.17M $14.68M $8.341M
YoY Change 21.7% 75.95% 5.64%
TOTAL ASSETS
Total Short-Term Assets $19.58M $21.78M $28.56M
Total Long-Term Assets $14.17M $14.68M $8.341M
Total Assets $33.75M $36.45M $36.90M
YoY Change -25.95% -1.2% 79.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.780M $1.494M $2.716M
YoY Change 12.75% -44.99% 37.91%
Accrued Expenses $1.108M $697.8K $629.2K
YoY Change -7.12% 10.9% -4.67%
Deferred Revenue $6.175K $21.45K $5.800K
YoY Change -96.61% 269.79% 2800.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $218.4K $217.6K $16.83K
YoY Change 22.19% 1192.81%
Total Short-Term Liabilities $4.561M $2.897M $3.854M
YoY Change 1.08% -24.84% 23.43%
LONG-TERM LIABILITIES
Long-Term Debt $3.035M $3.089M $572.6K
YoY Change -5.54% 439.43% 14.55%
Other Long-Term Liabilities $218.6K $327.7K $793.6K
YoY Change -67.24% -58.71% -30.76%
Total Long-Term Liabilities $3.253M $3.417M $1.366M
YoY Change -16.15% 150.09% -17.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.561M $2.897M $3.854M
Total Long-Term Liabilities $3.253M $3.417M $1.366M
Total Liabilities $7.814M $6.314M $5.220M
YoY Change -6.89% 20.94% 9.47%
SHAREHOLDERS EQUITY
Retained Earnings -$18.98M -$16.03M -$8.322M
YoY Change 96.55% 92.67% 159.33%
Common Stock $9.520K $9.520K $9.520K
YoY Change 0.0% 0.0% 36.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.62M $22.25M $27.75M
YoY Change
Total Liabilities & Shareholders Equity $33.75M $36.45M $36.90M
YoY Change -25.95% -1.2% 79.96%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$2.946M -$1.686M -$1.828M
YoY Change 54.73% -7.78% 53.48%
Depreciation, Depletion And Amortization $435.0K $425.3K $218.3K
YoY Change 52.85% 94.83% 172.54%
Cash From Operating Activities -$482.1K -$1.750M -$2.233M
YoY Change -59.74% -21.62% 94.2%
INVESTING ACTIVITIES
Capital Expenditures $1.724M $1.991M $744.0K
YoY Change 95.97% 167.61% 2.15%
Acquisitions
YoY Change
Other Investing Activities $0.00 $3.468M $501.0K
YoY Change -100.0% 592.12% 522.21%
Cash From Investing Activities -$1.724M $1.476M -$243.0K
YoY Change 317.85% -707.57% -62.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -53.29K -$83.74K -$2.835K
YoY Change -100.77% 2853.62% -97.56%
NET CHANGE
Cash From Operating Activities -482.1K -$1.750M -$2.233M
Cash From Investing Activities -1.724M $1.476M -$243.0K
Cash From Financing Activities -53.29K -$83.74K -$2.835K
Net Change In Cash -2.260M -$357.2K -$2.478M
YoY Change -142.52% -85.59% 29.5%
FREE CASH FLOW
Cash From Operating Activities -$482.1K -$1.750M -$2.233M
Capital Expenditures $1.724M $1.991M $744.0K
Free Cash Flow -$2.206M -$3.741M -$2.977M
YoY Change 6.21% 25.68% 58.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9520000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9520000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9520000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9520000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
9520 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
9520 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38274940 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
37848657 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16033211 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14346984 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
22251248 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
23511193 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
7889455 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
8538422 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30140703 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32049615 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36454352 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39846713 usd
CY2024Q1 us-gaap Revenues
Revenues
5276343 usd
CY2023Q1 us-gaap Revenues
Revenues
8877215 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
4999030 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
7267657 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
277314 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1609558 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
693954 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1022690 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
1296269 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
1737750 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
255325 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
297717 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
702648 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
2820520 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3979081 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2543206 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
149691 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2369523 usd
CY2024Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
213732 usd
CY2023Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
234510 usd
CY2024Q1 us-gaap Other Income
OtherIncome
38991 usd
CY2023Q1 us-gaap Other Income
OtherIncome
-1551 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-66950 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-51938 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
2577 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
22430 usd
CY2024Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-15548 usd
CY2023Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
8034 usd
CY2024Q1 VEEE Realized Gain On Marketable Securities
RealizedGainOnMarketableSecurities
35210 usd
CY2023Q1 VEEE Realized Gain On Marketable Securities
RealizedGainOnMarketableSecurities
0 usd
CY2024Q1 VEEE Employee Retention Credit Income
EmployeeRetentionCreditIncome
0 usd
CY2023Q1 VEEE Employee Retention Credit Income
EmployeeRetentionCreditIncome
329573 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
208012 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
541058 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-2335194 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-1828465 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2335194 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1828465 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-648967 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-661693 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1686227 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1166772 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9520000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9520000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9520000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9520000 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
33020889 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
482964 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31675388 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32049615 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
426283 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2335194 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30140703 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2335194 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1828465 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
426283 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
482964 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
425281 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
218276 usd
CY2024Q1 VEEE Change Of Rightofuse Asset And Lease Liabilities
ChangeOfRightofuseAssetAndLeaseLiabilities
119428 usd
CY2023Q1 VEEE Change Of Rightofuse Asset And Lease Liabilities
ChangeOfRightofuseAssetAndLeaseLiabilities
118206 usd
CY2024Q1 VEEE Net Change In Fair Value Of Marketable Securities
NetChangeInFairValueOfMarketableSecurities
-15548 usd
CY2023Q1 VEEE Net Change In Fair Value Of Marketable Securities
NetChangeInFairValueOfMarketableSecurities
8034 usd
CY2024Q1 VEEE Chane In Inventory Reserve
ChaneInInventoryReserve
113252 usd
CY2023Q1 VEEE Chane In Inventory Reserve
ChaneInInventoryReserve
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10712 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
611163 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-881527 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
788455 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-45954 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-263842 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-904756 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
650441 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-377715 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-611553 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-126069 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-119209 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-22747 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
500 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1749920 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2232650 usd
CY2024Q1 VEEE Payment To Security Deposit
PaymentToSecurityDeposit
-2709 usd
CY2023Q1 VEEE Payment To Security Deposit
PaymentToSecurityDeposit
-0 usd
CY2024Q1 VEEE Realized Gains On Marketable Securities Available For Sale
RealizedGainsOnMarketableSecuritiesAvailableForSale
35210 usd
CY2023Q1 VEEE Realized Gains On Marketable Securities Available For Sale
RealizedGainsOnMarketableSecuritiesAvailableForSale
-0 usd
CY2024Q1 VEEE Net Sales Of Investment In Trading Marketable Securities
NetSalesOfInvestmentInTradingMarketableSecurities
3500000 usd
CY2023Q1 VEEE Net Sales Of Investment In Trading Marketable Securities
NetSalesOfInvestmentInTradingMarketableSecurities
501001 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1991051 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
744008 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1476448 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-243007 usd
CY2024Q1 VEEE Proceeds From Repayment Of Finance Lease
ProceedsFromRepaymentOfFinanceLease
-83735 usd
CY2023Q1 VEEE Proceeds From Repayment Of Finance Lease
ProceedsFromRepaymentOfFinanceLease
-2835 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-83735 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2835 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-357207 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2478492 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16755233 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23501007 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16398027 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21022515 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
51978 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
59895 usd
CY2024Q1 VEEE Increase In Rightofuse Asset And Lease Liability
IncreaseInRightofuseAssetAndLeaseLiability
31572 usd
CY2023Q1 VEEE Increase In Rightofuse Asset And Lease Liability
IncreaseInRightofuseAssetAndLeaseLiability
92405 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16137920 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21022515 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
260107 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16398027 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21022515 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
21448 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44195 usd
CY2023Q1 VEEE Increase In Cost Of Sales
IncreaseInCostOfSales
1612272 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zwyDp5bEyzn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_863_z8pX8TkQfZp6">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zpAgt7qYVtkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_zD3csnBqWSxi">Concentrations of Credit and Business Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of trade receivables. Credit risk on trade receivables is mitigated as a result of the Company’s use of trade letters of credit, dealer floor plan financing arrangements, and the geographically diversified nature of the Company’s customer base. The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_90C_eus-gaap--CashFDICInsuredAmount_pp0p0_c20240331_zrV6BuEH6io7" title="FDIC insured limit">250,000</span> are at risk. As of March 31, 2024 and December 31, 2023, the Company had $<span id="xdx_904_eus-gaap--CashUninsuredAmount_pp0p0_c20240331_zO3ZXuqDRcB8" title="FDIC uninsured amount">15,562,629</span> and $<span id="xdx_900_eus-gaap--CashUninsuredAmount_pp0p0_c20231231_zuJ2NgXTbOBl" title="FDIC uninsured amount">15,868,574</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
15562629 usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
15868574 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16398027 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16755233 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
260107 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
257530 usd
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
34589 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
125039 usd
CY2024Q1 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
149691 usd
CY2023Q1 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
702648 usd
CY2024Q1 VEEE Shipping And Handling Costs
ShippingAndHandlingCosts
134466 usd
CY2023Q1 VEEE Shipping And Handling Costs
ShippingAndHandlingCosts
185532 usd
CY2024Q1 VEEE Accounts Payable Related Party
AccountsPayableRelatedParty
1709801 usd
CY2023Q1 VEEE Accounts Payable Related Party
AccountsPayableRelatedParty
1870425 usd
CY2024Q1 VEEE Employee Retention Credit
EmployeeRetentionCredit
0 usd
CY2023Q1 VEEE Employee Retention Credit
EmployeeRetentionCredit
329573 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13891330 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12293988 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
425281 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
218276 usd
CY2024Q1 VEEE Marketable Securities Amortized Cost
MarketableSecuritiesAmortizedCost
1002050 usd
CY2024Q1 VEEE Marketable Securities Gross Unrealized Gains
MarketableSecuritiesGrossUnrealizedGains
12697 usd
CY2024Q1 VEEE Marketable Securities Gross Unrealized Losses
MarketableSecuritiesGrossUnrealizedLosses
-32143 usd
CY2024Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
982604 usd
CY2023Q4 VEEE Marketable Securities Amortized Cost
MarketableSecuritiesAmortizedCost
4473033 usd
CY2023Q4 VEEE Marketable Securities Gross Unrealized Gains
MarketableSecuritiesGrossUnrealizedGains
50878 usd
CY2023Q4 VEEE Marketable Securities Gross Unrealized Losses
MarketableSecuritiesGrossUnrealizedLosses
-60969 usd
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
4462942 usd
CY2024Q1 us-gaap Marketable Securities
MarketableSecurities
982604 usd
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
4462942 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
4245247 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5001512 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
72797 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
96721 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
104806 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
206144 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
4422850 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
5304377 usd
CY2024Q1 VEEE Reserve For Excess And Obsolete
ReserveForExcessAndObsolete
532868 usd
CY2023Q4 VEEE Reserve For Excess And Obsolete
ReserveForExcessAndObsolete
419616 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
3889982 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
4884761 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16696926 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14676820 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2805596 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2382832 usd
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
217583 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
214715 usd
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2589092 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2644123 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
2806675 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
2858838 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
223688 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
298249 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
296033 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
292051 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
1986655 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
3096676 usd
CY2024Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
290001 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
2806675 usd
CY2024Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0307 pure
CY2024Q1 us-gaap Lessee Finance Lease Remaining Lease Term
LesseeFinanceLeaseRemainingLeaseTerm
P4Y2M1D
CY2024Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
130592 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
343511 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
116340 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
33245 usd
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
91968 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
0 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
35000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
0 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
142189 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
115037 usd
CY2024Q1 VEEE Accrued Consturction Expense
AccruedConsturctionExpense
0 usd
CY2023Q4 VEEE Accrued Consturction Expense
AccruedConsturctionExpense
390825 usd
CY2024Q1 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
181709 usd
CY2023Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
192894 usd
CY2024Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
697798 usd
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1075512 usd
CY2024Q1 VEEE Income Loss From Operations
IncomeLossFromOperations
-2543207 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
208012 usd
CY2024Q1 VEEE Net Loss
NetLoss
-2335194 usd
CY2023Q1 us-gaap Revenues
Revenues
8877215 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6611 usd
CY2024Q1 VEEE Long Term Debt Maturities Repayments Of Principal After Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearThree
493289 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
499900 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
7500 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
7500 usd
CY2024Q1 us-gaap Contractual Obligation
ContractualObligation
13176754 usd
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
10510252 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
260107 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
257530 usd
CY2024Q1 us-gaap Revenues
Revenues
5276343 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
4999030 usd
CY2024Q1 VEEE Operating Expense
OperatingExpense
2820520 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
7267657 usd
CY2023Q1 VEEE Operating Expense
OperatingExpense
3979081 usd
CY2023Q1 VEEE Income Loss From Operations
IncomeLossFromOperations
-2369523 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
541058 usd
CY2023Q1 VEEE Net Loss
NetLoss
-1828465 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001731122-24-000812-index-headers.html Edgar Link pending
0001731122-24-000812-index.html Edgar Link pending
0001731122-24-000812.txt Edgar Link pending
0001731122-24-000812-xbrl.zip Edgar Link pending
e5664_10q.htm Edgar Link pending
e5664_ex31-1.htm Edgar Link pending
e5664_ex31-2.htm Edgar Link pending
e5664_ex32-1.htm Edgar Link pending
e5664_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
e5664_10q_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
veee-20240331.xsd Edgar Link pending
veee-20240331_def.xml Edgar Link unprocessable
veee-20240331_lab.xml Edgar Link unprocessable
veee-20240331_pre.xml Edgar Link unprocessable
veee-20240331_cal.xml Edgar Link unprocessable